Treating liver failure depends on whether it develops suddenly (acute) or gradually over months to years (chronic). Acute liver failure is a medical emergency that requires intensive care and, in many cases, a liver transplant. Chronic liver failure from cirrhosis is managed by treating complications one by one, slowing further damage, and evaluating whether transplant is needed. Both forms demand hospital-level care, and the earlier treatment begins, the better the outcomes.
Acute Liver Failure: Emergency Treatment
Acute liver failure means the liver shuts down within days or weeks, often in someone who had no prior liver disease. The most common cause is acetaminophen (Tylenol) overdose, though viral hepatitis, drug reactions, and autoimmune conditions can also trigger it. Patients are admitted to an ICU and contacted with a transplant center early, because the window for intervention is narrow.
When acetaminophen is the cause, the primary treatment is a medication called N-acetylcysteine, or NAC, which helps the liver neutralize the toxic byproducts of the overdose. NAC can be given by mouth or through an IV, and it works best when started within hours of the overdose. If the patient arrives within four hours, activated charcoal is given first to absorb any remaining drug in the stomach. Even in cases not caused by acetaminophen, IV NAC has shown benefit for early-stage acute liver failure and is often used broadly.
Beyond that specific treatment, the rest of the care is supportive: keeping the body stable while hoping the liver regenerates or while arranging a transplant. That means IV fluids to maintain blood pressure, medications to prevent stomach bleeding from stress, vitamin K to help with clotting problems, and close monitoring of kidney function. If blood pressure drops despite fluids, vasopressor medications are used to keep circulation adequate.
Managing Brain Swelling in Acute Failure
One of the most dangerous complications of acute liver failure is swelling in the brain, called cerebral edema. When the liver stops clearing ammonia and other toxins from the blood, those substances build up and affect brain function. This starts as confusion and disorientation (hepatic encephalopathy) and can progress to coma.
Patients who deteriorate to severe confusion or unresponsiveness are placed on a ventilator and positioned with the head elevated at 30 degrees. Stimulation and pain are minimized to reduce pressure inside the skull. If brain swelling worsens, the first-line treatment is an IV infusion of a substance that draws fluid out of the brain tissue. Salt concentration in the blood may also be deliberately raised to help reduce swelling. In extreme cases, cooling the body temperature down a few degrees can buy time until a transplant liver becomes available.
Chronic Liver Failure: Treating Cirrhosis Complications
Chronic liver failure develops over years, most often from long-term alcohol use, chronic hepatitis B or C, or fatty liver disease. By the time the liver is failing, it’s usually heavily scarred (cirrhotic), and treatment shifts to managing the cascade of problems that cirrhosis creates. The liver itself can’t be repaired at this stage, but controlling complications can extend life significantly and keep patients stable enough for transplant evaluation.
Fluid Buildup in the Abdomen
Ascites, the accumulation of fluid in the belly, is one of the most common signs of advanced cirrhosis. It’s treated with a combination of two water pills that work together: spironolactone, which blocks a hormone that causes salt retention, and furosemide, which helps the kidneys flush out extra fluid. A typical starting combination is 100 mg of spironolactone with 40 mg of furosemide, and doses can be increased together up to 400 mg and 160 mg respectively if fluid continues to build.
When the fluid accumulation is massive, a procedure called large-volume paracentesis drains it directly through a needle inserted into the abdomen. If more than 5 liters are removed in a single session, an albumin infusion (8 grams per liter removed) is given afterward to prevent a dangerous drop in blood pressure. Some patients need this procedure repeated every few weeks.
Hepatic Encephalopathy
When a failing liver can’t clear ammonia from the bloodstream, the ammonia reaches the brain and causes symptoms ranging from mild confusion and personality changes to severe disorientation and coma. The mainstay treatment is lactulose, a synthetic sugar that works in the colon. It acidifies the gut environment, which traps ammonia in a form that can’t be absorbed back into the blood. It also acts as a laxative, flushing ammonia out with frequent bowel movements. During an acute episode, lactulose is given until mental status improves. For ongoing prevention, the dose is adjusted to produce two to three bowel movements per day.
An antibiotic called rifaximin is often added alongside lactulose for patients who’ve had repeated episodes. It works inside the gut without being absorbed into the body, reducing the bacteria that produce ammonia in the first place. The combination of lactulose and rifaximin is more effective than either alone at preventing encephalopathy from coming back.
Bleeding From Swollen Veins
Cirrhosis creates back-pressure in the veins that feed the liver, forcing blood into smaller vessels that weren’t designed to handle it. The veins in the lower esophagus and stomach can balloon into varices, which carry a high risk of life-threatening bleeding. Before any bleeding occurs, patients with significant varices are started on a type of blood pressure medication (a nonselective beta blocker) that reduces pressure in these veins. For patients who can’t tolerate the medication, the varices can be treated with endoscopic banding, where small rubber bands are placed around each swollen vein during an upper endoscopy to cut off blood flow.
Abdominal Infections
Patients with ascites are vulnerable to a specific type of abdominal infection called spontaneous bacterial peritonitis, where bacteria migrate into the fluid without an obvious source like a ruptured organ. It’s diagnosed by testing the fluid: if the white blood cell count (specifically neutrophils) exceeds 250 per cubic millimeter, infection is confirmed and IV antibiotics are started immediately. Patients who’ve had one episode are put on a daily preventive antibiotic to reduce the risk of recurrence, since repeat infections are common and each one carries serious mortality risk.
Alcohol-Related Liver Failure
Severe alcoholic hepatitis is a specific and particularly deadly form of liver failure that develops after heavy, prolonged drinking. It can kill within weeks. Severity is assessed using scoring systems that factor in lab values like bilirubin, clotting time, and kidney function. Patients who score above certain thresholds, indicating high short-term mortality risk, may be treated with corticosteroids to reduce the intense inflammation destroying the liver.
Corticosteroids don’t work for everyone, though, and continuing them in non-responders increases infection risk without improving survival. Doctors reassess the response after about four to seven days using a calculation that compares the change in bilirubin levels. Patients whose bilirubin hasn’t improved meaningfully by that point are taken off steroids, since continuing offers no benefit and may cause harm. Among those who don’t respond, six-month survival drops to roughly 25%, compared to 85% in responders.
Liver Transplant: When Other Treatments Aren’t Enough
Transplant is the definitive treatment when the liver has failed beyond recovery. Candidates are prioritized on the national waiting list using a scoring system called MELD 3.0 (Model for End-Stage Liver Disease), which calculates urgency based on blood tests measuring bilirubin, creatinine, clotting time, sodium, and albumin levels. Higher scores reflect greater short-term mortality risk and move patients higher on the list. The updated MELD 3.0 formula also includes a sex-based adjustment, addressing a longstanding disparity in transplant access.
Outcomes after liver transplant are strong. According to the Scientific Registry of Transplant Recipients, one-year survival for transplant recipients is 93.5%, and five-year survival is 81%. At ten years, roughly two-thirds of recipients are still alive. These numbers reflect improvements in surgical technique, organ preservation, and post-transplant care over the past two decades.
For patients in acute liver failure awaiting a donor organ, artificial liver support devices can serve as a temporary bridge. Systems like the Molecular Adsorbent Recirculating System (MARS) work by passing the patient’s blood along one side of a special membrane while an albumin solution flows on the other side. Toxins that are normally bound to proteins in the blood cross the membrane and get carried away by the albumin, essentially doing the detoxification work the liver can no longer perform. These devices don’t replace the liver’s full function, but they can stabilize patients long enough to reach transplant.
Stopping Further Liver Damage
Regardless of the cause, halting the process that damaged the liver is a critical part of treatment. For alcohol-related disease, that means complete and permanent abstinence. For chronic hepatitis B, antiviral medications suppress the virus indefinitely. Hepatitis C can now be cured with an 8- to 12-week course of direct-acting antivirals, and curing the virus can halt or even partially reverse early cirrhosis. For fatty liver disease, weight loss of 7 to 10% of body weight has been shown to reduce liver inflammation and scarring.
Patients with cirrhosis also need regular screening for liver cancer, typically with an ultrasound every six months, since a failing liver is at significantly higher risk of developing tumors. Catching cancer early can make the difference between being eligible for transplant and being too advanced for it.